Cargando…
The role of interferons in ovarian cancer progression: Hinderer or promoter?
Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810991/ https://www.ncbi.nlm.nih.gov/pubmed/36618371 http://dx.doi.org/10.3389/fimmu.2022.1087620 |
_version_ | 1784863432258879488 |
---|---|
author | Liu, Taiqing Li, Yinqi Wang, Xiaoyu Yang, Xiaodong Fu, Yunhai Zheng, Yeteng Gong, Hanlin He, Zhiyao |
author_facet | Liu, Taiqing Li, Yinqi Wang, Xiaoyu Yang, Xiaodong Fu, Yunhai Zheng, Yeteng Gong, Hanlin He, Zhiyao |
author_sort | Liu, Taiqing |
collection | PubMed |
description | Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of important cytokines. IFNs have a bidirectional regulation for OC cells growth and survival. Meanwhile, IFNs positively regulate the recruitment, differentiation and activation of immune cells. This review summarizes the secretion and the role of IFNs. In particular, we mainly elucidate the actions played by IFNs in various types of therapy. IFNs assist radiotherapy, targeted therapy, immunotherapy and biotherapy for OC, except for some IFN pathways that may cause chemo-resistance. In addition, we present some advances in OC treatment with the help of IFN pathways. IFNs have the ability to powerfully modulate the tumor microenvironment and can potentially provide new combination strategies for OC treatment. |
format | Online Article Text |
id | pubmed-9810991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98109912023-01-05 The role of interferons in ovarian cancer progression: Hinderer or promoter? Liu, Taiqing Li, Yinqi Wang, Xiaoyu Yang, Xiaodong Fu, Yunhai Zheng, Yeteng Gong, Hanlin He, Zhiyao Front Immunol Immunology Ovarian cancer (OC) is a common gynecologic malignancy with poor prognosis and high mortality. Changes in the OC microenvironment are closely related to the genesis, invasion, metastasis, recurrence, and drug-resistance. The OC microenvironment is regulated by Interferons (IFNs) known as a type of important cytokines. IFNs have a bidirectional regulation for OC cells growth and survival. Meanwhile, IFNs positively regulate the recruitment, differentiation and activation of immune cells. This review summarizes the secretion and the role of IFNs. In particular, we mainly elucidate the actions played by IFNs in various types of therapy. IFNs assist radiotherapy, targeted therapy, immunotherapy and biotherapy for OC, except for some IFN pathways that may cause chemo-resistance. In addition, we present some advances in OC treatment with the help of IFN pathways. IFNs have the ability to powerfully modulate the tumor microenvironment and can potentially provide new combination strategies for OC treatment. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9810991/ /pubmed/36618371 http://dx.doi.org/10.3389/fimmu.2022.1087620 Text en Copyright © 2022 Liu, Li, Wang, Yang, Fu, Zheng, Gong and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Liu, Taiqing Li, Yinqi Wang, Xiaoyu Yang, Xiaodong Fu, Yunhai Zheng, Yeteng Gong, Hanlin He, Zhiyao The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title | The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title_full | The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title_fullStr | The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title_full_unstemmed | The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title_short | The role of interferons in ovarian cancer progression: Hinderer or promoter? |
title_sort | role of interferons in ovarian cancer progression: hinderer or promoter? |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810991/ https://www.ncbi.nlm.nih.gov/pubmed/36618371 http://dx.doi.org/10.3389/fimmu.2022.1087620 |
work_keys_str_mv | AT liutaiqing theroleofinterferonsinovariancancerprogressionhindererorpromoter AT liyinqi theroleofinterferonsinovariancancerprogressionhindererorpromoter AT wangxiaoyu theroleofinterferonsinovariancancerprogressionhindererorpromoter AT yangxiaodong theroleofinterferonsinovariancancerprogressionhindererorpromoter AT fuyunhai theroleofinterferonsinovariancancerprogressionhindererorpromoter AT zhengyeteng theroleofinterferonsinovariancancerprogressionhindererorpromoter AT gonghanlin theroleofinterferonsinovariancancerprogressionhindererorpromoter AT hezhiyao theroleofinterferonsinovariancancerprogressionhindererorpromoter AT liutaiqing roleofinterferonsinovariancancerprogressionhindererorpromoter AT liyinqi roleofinterferonsinovariancancerprogressionhindererorpromoter AT wangxiaoyu roleofinterferonsinovariancancerprogressionhindererorpromoter AT yangxiaodong roleofinterferonsinovariancancerprogressionhindererorpromoter AT fuyunhai roleofinterferonsinovariancancerprogressionhindererorpromoter AT zhengyeteng roleofinterferonsinovariancancerprogressionhindererorpromoter AT gonghanlin roleofinterferonsinovariancancerprogressionhindererorpromoter AT hezhiyao roleofinterferonsinovariancancerprogressionhindererorpromoter |